Screener
ANI Pharmaceuticals ANIP PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Investment in equity securities | 15,626 | 9,131 |
| Total Current Assets | 825,433 | 753,117 |
| Non-current Assets | ||
| Property and equipment, net | 73,223 | 62,476 |
| Deferred tax assets, net | 71,495 | 69,072 |
| Intangible assets, net | 449,857 | 479,526 |
| Goodwill | 62,480 | 62,480 |
| Other non-current assets | 11,624 | 13,706 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's PP&E (net)?
- ANI Pharmaceuticals (ANIP) reported PP&E (net) of $73.22M in Q2 2026.
- How has ANI Pharmaceuticals's PP&E (net) changed year-over-year?
- ANI Pharmaceuticals's PP&E (net) increased by 23.6% year-over-year, from $59.25M to $73.22M.
- What is the long-term trend for ANI Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's PP&E (net) has grown at a 8.6% compound annual growth rate (CAGR), from $41.27M to $62.48M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about ANI Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude